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Clinics and pathology 
Disease 
Myeloproliferative disorder (atypical chronic 
myelogenous leukaemia (a-CML)). 
Note: BCR-ABL negative myeloproliferative disease 
undistinguishable from CML otherwise. 
Epidemiology 
Only one case to date, a 32-year-old female patient. 
Prognosis 
Unknown; the patient received bone marrow 
transplantation, relapsed 4 years later, and was in 
complete remission 6 months after treatment of the 
relapse. 
Genes involved and Proteins 
SPTBN1 
Protein 
Scaffold protein; forms homo-tetrameres; non-
erythrocytic beta-spectrin; joins the actin cytoskeleton 




Class III receptor tyrosine kinase (RTK); promotes 
signalling through posphorylation of multiple proteins 
and activation of several downstream signalling 
pathways, such as the Ras/Raf/MAPK and PI3 kinase 
cascades. 




Fusion of exon 3 of SPTBN1 and exon 13 of FLT3. 
Fusion protein 
Description 
Encodes a 66 kDa protein which retains the 2 coiled-
coil domains of SPTBN1 and the tyrosine kinase 
domain of FLT3. 
Expression localisation 
 Expresssion of the fusion protein transformed Ba/F3 
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